Filing search / Intellia Therapeutics, Inc. / "Audit"

Search information

Intellia Therapeutics, Inc.

Companies

"Audit"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

154 results

Newest first Best match first

10-K

2024 FY

EX-31.1

NTLA Intellia Therapeutics, Inc.

Annual report

of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons

27 Feb 25

4:03pm

10-K

2024 FY

EX-31.2

NTLA Intellia Therapeutics, Inc.

Annual report

of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons

27 Feb 25

4:03pm

10-K

2024 FY

NTLA Intellia Therapeutics, Inc.

Annual report

and tissue products; positive results from potential FDA audit of the nonclinical study and clinical trial sites that generated the data in support … ://www.sec.gov. A copy of our Corporate Governance Guidelines, Code of Conduct and Business Ethics and the charters of the Audit Committee

27 Feb 25

4:03pm

10-K

2024 FY

EX-19.1

NTLA Intellia Therapeutics, Inc.

Annual report

approved by the Audit Committee prior to the effective date of this Policy. c.No Hedging Transactions. Covered Persons may not engage in hedging … officers of the Company may only be granted by the chair of the Audit Committee of the Board of Directors of the Company. Such executive officers

27 Feb 25

4:03pm

8-K

NTLA Intellia Therapeutics, Inc.

10 Jan 25

Intellia Therapeutics Announces Anticipated 2025 Milestones and Pipeline priorities result in NTLA-3001 discontinuation and select, research-focused investment

7:30am

financial condition as of December 31, 2024. The audit of the Company’s consolidated financial statements for the year ended December 31, 2024, is ongoing

10-Q

erv43uccz

Quarterly report

7 Nov 24

4:05pm

7 Nov 24

4:05pm

7 Nov 24

4:05pm

8 Aug 24

4:06pm

10-Q

0dxb z6stig

Quarterly report

8 Aug 24

4:06pm

8 Aug 24

4:06pm

8 Aug 24

4:06pm

10-Q

zpvm3vlcgr9

Quarterly report

9 May 24

4:25pm

9 May 24

4:25pm

9 May 24

4:25pm

9 May 24

4:25pm

DEF 14A

5y44 u1re8

Definitive proxy

29 Apr 24

4:16pm

PRE 14A

wl1oj2g4eg1npgp uvq

Preliminary proxy

16 Apr 24

4:10pm

8-K

f2um ul9egx38c

15 Apr 24

Departure of Directors or Certain Officers

22 Feb 24

4:02pm

Filing search / Intellia Therapeutics, Inc. / "Audit"

154 results

Top filers

Top filing types

Recent filing years